||25% of survey complete.|
The New York Times recently reported: "A growing body of evidence suggests that doctors at some of the nation’s top medical schools have been attaching their names and lending their reputations to scientific papers that were drafted by ghostwriters working for drug companies -- articles that were carefully calibrated to help the manufacturers sell more products.
"Senator Charles E. Grassley, an Iowa Republican who has led a long-running investigation of conflicts of interest in medicine, is starting to put pressure on the National Institutes of Health to crack down on the practice."
According to pharma blogger Rich Meyer, "Medical journal articles sponsored by drug companies are part of marketing. That is a fact of a capitalist business that has to market to medical professionals. 'Ghostwriting' has been around for over 20 years and is standard industry practice for the drug industries. I personally see nothing wrong with ghostwriting as long as it is made clear at the beginning of the article who wrote it and who endorses the content."
What do YOU think?
Please take 2 minutes to answer a few short questions relating to medical article ghostwriting practices sponsored by pharmaceutical companies.
For some background on this topic, see
- "Ghostwriting: What is right and wrong"
- "Sen Grassley puts pressure on NIH to crack down on ghostwriters"
Results of this survey will be summarized in an issue of Pharma Marketing News.
Your comments are confidential (anonymous) unless you specifically provide your contact information at the end of the survey and allow us to attribute comments to you personally.
At the end you will be able to access a de-identified summary of the results of this survey to date.